Paraproteinemia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01002755) | M.D. Anderson Cancer Center | 2010-01-19 |
Track Paraproteinemia automatically
Every clearance here is in the API, with alerts when new ones post.